Table 1.
Demographic characteristics of COVID-19 cases and the control cohort.
| COVID-19 hospitalized | COVID-19 outpatient | p value | fire brigade | children and adolescents (2011–2012) | respiratory infection | coeliac disease | |
|---|---|---|---|---|---|---|---|
| N | 51 | 65 | 64 | 50 | 8 | 17 | |
| Males (%) | 64.7 | 67.7 | n.s. | 89.1 | 36.0 | 87.5 | 35.3 |
| Median age | 64 (25–90) | 46 (14–64) | 0.012 | 38 (19–65) | 13 (5–18) | 57 (17–88) | 13 (7–55) |
| Blood sampling | 9 (0–60) | 36 (24–67) | <0.001 | ||||
| CT values | 26.7 (11.8–34.1) | 21.6 (15.4–32.4) | n.s. | ||||
| Severity of disease | |||||||
| 0 – asymptomatic | 2 | 5 | n.s. | ||||
| 1 – moderate | 14 | 60 | <0.001 | ||||
| 2 – severe | 23 | – | <0.001 | ||||
| 3 – critical | 12 | – | <0.001 |
Data is presented as the median with minimum and maximum. Clinical severity was classified as asymptomatic (0); moderate (1): uncomplicated upper airway symptoms without requirement of supplemental oxygen, none respiratory symptoms (vomiting/diarrhea/fever); severe (2): receiving supplemental oxygen, Sp02 ≤90%, PaFiO2 ratio <300 mmHg, respiratory rate >30/min; critical (3): receiving ventilatory support (nasal high-flow, noninvasive ventilation, invasive ventilation), multiple organ failure. Mann-Whitney-U test was used to analyze differences. n.s. = not significant.